Keywords: Spain, Pricing pressure, Public health debt to pharma, Almirall, Zeltia, Grifols

The solution for Spanish pharma companies lies abroad

Article | 13 March 2013

Print This

The pressure on the prices of medicines by Spanish government has seen the pharmaceutical market in Spain declined more than 7% ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in